Premas Biotech designs multi sub-unit COVID vaccine with three antigens. Gurgaon-based Premas Biotech is a biotechnology enterprise. The vaccine has the Spike (S), Envelope (E), and Membrane (M) proteins in multiple formats. Aim is to overcome known and possible mutations of the coronavirus. Premas has completed expression of the 3 antigens and will move on to scale-up designs.